# FDA Warning Letter: Bioptimal International
> 2024-05-07 · "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality" · `87937e7b6a2d33fe`
## Letter
- **Company:** Bioptimal International
- **Posted Date:** 2024-05-07
- **Letter Issue Date:** 2024-04-03
- **Issuing Office:** "OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality"
## Subject
CGMP/QSR/Medical Devices/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*